651 related articles for article (PubMed ID: 29186429)
1. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis.
Islam MS; Akhtar MM; Segars JH; Castellucci M; Ciarmela P
Crit Rev Food Sci Nutr; 2017 Nov; 57(17):3583-3600. PubMed ID: 28609115
[TBL] [Abstract][Full Text] [Related]
4. Uterine leiomyoma: available medical treatments and new possible therapeutic options.
Islam MS; Protic O; Giannubilo SR; Toti P; Tranquilli AL; Petraglia F; Castellucci M; Ciarmela P
J Clin Endocrinol Metab; 2013 Mar; 98(3):921-34. PubMed ID: 23393173
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
6. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
8. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
9. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
Islam MS; Afrin S; Singh B; Jayes FL; Brennan JT; Borahay MA; Leppert PC; Segars JH
Clin Transl Med; 2021 Jul; 11(7):e475. PubMed ID: 34323413
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.
Qiang W; Liu Z; Serna VA; Druschitz SA; Liu Y; Espona-Fiedler M; Wei JJ; Kurita T
Endocrinology; 2014 Mar; 155(3):663-9. PubMed ID: 24424054
[TBL] [Abstract][Full Text] [Related]
12. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
Yoshida S; Ohara N; Xu Q; Chen W; Wang J; Nakabayashi K; Sasaki H; Morikawa A; Maruo T
Semin Reprod Med; 2010 May; 28(3):260-73. PubMed ID: 20414849
[TBL] [Abstract][Full Text] [Related]
13. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women.
Malik M; Norian J; McCarthy-Keith D; Britten J; Catherino WH
Semin Reprod Med; 2010 May; 28(3):169-79. PubMed ID: 20414841
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.
Lewis TD; Malik M; Britten J; San Pablo AM; Catherino WH
Biomed Res Int; 2018; 2018():2414609. PubMed ID: 29780819
[TBL] [Abstract][Full Text] [Related]
15. Role of Transforming Growth Factor β in Uterine Fibroid Biology.
Ciebiera M; Włodarczyk M; Wrzosek M; Męczekalski B; Nowicka G; Łukaszuk K; Ciebiera M; Słabuszewska-Jóźwiak A; Jakiel G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149020
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
17. Activin A induces leiomyoma cell proliferation, extracellular matrix (ECM) accumulation and myofibroblastic transformation of myometrial cells via p38 MAPK.
Bao H; Sin TK; Zhang G
Biochem Biophys Res Commun; 2018 Oct; 504(2):447-453. PubMed ID: 30195496
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
19. Mechanical Signaling and Extracellular Matrix in Uterine Fibroids.
Rafique S; Segars JH; Leppert PC
Semin Reprod Med; 2017 Nov; 35(6):487-493. PubMed ID: 29100236
[No Abstract] [Full Text] [Related]
20. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
